Bevantolol
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (RS)-[2-(3,4-dimethoxyphenyl)ethyl][2-hydroxy-3-(3-methylphenoxy)propyl]amine | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | Oral |
| Identifiers | |
| CAS number | 59170-23-9 |
| ATC code | C07AB06 |
| PubChem | CID 2372 |
| DrugBank | DB01295 |
| ChemSpider | 2282 |
| UNII | 34ZXW6ZV21 |
| ChEBI | CHEBI:238698 |
| ChEMBL | CHEMBL314010 |
| Chemical data | |
| Formula | C20H27NO4 |
| Mol. mass | 345.43 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Bevantolol (INN) is a drug which acts as both a beta blocker and a calcium channel blocker.
|
| This article about an amine is a stub. You can help Wikipedia by expanding it. |
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |

